Institutional Ownership
Eli Lilly & Co
CUSIP 532457108COMLLYQ1 2026
13D / 13G Filings
28
Schedule 13D/13G on record
Beneficial Filers
7
Distinct reporting persons
Largest Stake
11.9%
Max % of class reported
Institutional Holders
4,311
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
28 filings · latest Jan 23, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 23, 2026 | Lilly Endowment, Inc. | 13G/A | 9.8% | 92.19M | SEC |
| 2 | Oct 30, 2025 | Lilly Endowment, Inc. | 13G/A | 10.1% | 95.49M | SEC |
| 3 | Oct 30, 2025 | The Vanguard Group | 13G/A | 8.6% | 80.95M | SEC |
| 4 | Apr 16, 2025 | Lilly Endowment Inc | 13G/A | 10.1% | 96.02M | SEC |
| 5 | Feb 7, 2025 | The Pnc Financial Services Group, Inc. | 13G/A | 5.4% | 51.15M | SEC |
| 6 | Jan 27, 2025 | Lilly Endowment Inc | 13G/A | 10.2% | 96.89M | SEC |
| 7 | Nov 14, 2024 | Pnc Financial Services Group, Inc. | 13G/A | 5.4% | 51.21M | SEC |
| 8 | Oct 23, 2024 | Lilly Endowment Inc | 13G/A | 10.2% | 96.89M | SEC |
| 9 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 7.5% | 71.60M | SEC |
| 10 | Feb 9, 2024 | Pnc Financial Services Group, Inc. | 13G/A | 5.4% | 51.54M | SEC |
18 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Eli Lilly & Co.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Lilly Endowment Inc | 91.90M | $84.52B |
| 2 | Blackrock, Inc. | 66.38M | $61.06B |
| 3 | Pnc Financial Services Group, Inc. | 51.33M | $47.21B |
| 4 | State Street Corp | 35.61M | $32.75B |
| 5 | Fmr LLC | 26.34M | $24.23B |
| 6 | Capital Research Global Investors | 24.63M | $22.65B |
| 7 | Geode Capital Management, LLC | 20.19M | $18.51B |
| 8 | Capital World Investors | 15.62M | $14.37B |
| 9 | Morgan Stanley | 15.44M | $14.20B |
| 10 | Wellington Management Group LLP | 13.43M | $12.35B |